Wei Wu He
Chief Executive Officer bij CASI PHARMACEUTICALS, INC.
Oorsprong van het eerstegraads netwerk van Wei Wu He
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 10 | |
J. Craig Venter Institute, Inc.
 J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services J. Craig Venter Institute, Inc. operates as a not-for-profit genomics research organization. It conducts research on human genomic medicine, infectious diseases, plant genomics, microbial and environmental genomics, synthetic biology and biological energy, bioinformatics, and software engineering. The firm also develops a suite of software packages for sequencing/assembly, gene finding, annotation, genome analysis, microarray data analysis and normalization, protein expression quantitation, computational management, and cloud-based bioinformatics. The company was founded by J. Craig Venter and Hamilton O. Smith in October 2006 and is headquartered in Rockville, MD.
8
| Private Company | Miscellaneous Commercial Services | 8 |
OriGene Technologies, Inc.
 OriGene Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services OriGene Technologies, Inc. engages in the development of products for pharmaceutical, biotechnology, and academic research. It offers CDNA clones, antibodies, assay kits, vectors, RNA Interference (RNAi), tissues, proteins, genome editing, and other products. The company was founded by Wei-Wu He in 1996 and is headquartered in Rockville, MD.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA.
6
| Holding Company | Biotechnology | 6 |
Beijing Genetron Health Gene Technology Co., Ltd.
 Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China.
5
| Subsidiary | Information Technology Services | 5 |
Emerging Technology Partners LLC
 Emerging Technology Partners LLC Investment ManagersFinance Emerging Technology Partners LLC (ETP) is a venture capital firm founded in 2000 by Wei-Wu He and Bill Snider. The firm is headquartered in San Francisco, California.
2
| Private Company | Investment Managers | 2 |
Beijing Genetron Biotechnology Co. Ltd.
 Beijing Genetron Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Genetron Biotechnology Co. Ltd. provides healthcare solutions. It offers Cancer Genetic Testing, DNA Methylation Sequencing, RNA Sequencing, Whole-Exome Sequencing and Glioma Panel. The company was founded in December 2013 by Si-Zhen Wang and Hai Yan and is headquartered in Beijing, China.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
MithraGen, Inc.
 MithraGen, Inc. Pharmaceuticals: MajorHealth Technology MithraGen, Inc. develops immunotherapies for the treatment and prevention of cancer and infectious diseases. The company was founded in 2000 and is headquartered in Houston, TX.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Wei Wu He via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member | |
| SCINOPHARM TAIWAN, LTD. | Biotechnology | Director/Board Member Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| UNI-PRESIDENT ENTERPRISES CORP. | Food Retail | Corporate Officer/Principal | |
| PRESIDENT CHAIN STORE CORPORATION | Food Retail | Director/Board Member | |
| KNH ENTERPRISE CO., LTD. | Pulp & Paper | Director/Board Member Director/Board Member | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree Graduate Degree | |
| President Life Sciences Co., Ltd. | Chief Executive Officer Director/Board Member | ||
| University of California, Los Angeles | College/University | Graduate Degree Masters Business Admin | |
| VCANBIO CELL & GENE ENGINEERING CORP., LTD | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of Illinois | College/University | Undergraduate Degree Doctorate Degree | |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Outlook Investment Pte Ltd. | Director/Board Member Director/Board Member | ||
| Ben-Gurion University of the Negev | College/University | Doctorate Degree | |
| Renmin University of China | College/University | Masters Business Admin Graduate Degree | |
Grand Bills Finance Corp.
 Grand Bills Finance Corp. Investment Banks/BrokersFinance Grand Bills Finance Corp. issues commercial papers, bills, and government bonds. The private company is based in Taipei, Taiwan. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Chiral Quest (Suzhou) Co., Ltd.
 Chiral Quest (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chiral Quest (Suzhou) Co. Ltd. provides drug discovery services. It focuses on the development and manufacture of chiral catalysts, development of synthetic processes, and a technology applications platform. Its products include a, b, and Cyclicb-amino acids; b-hydroxy acids; chiral amines, alcohols, amino alcohols, and pyrrolidines; succinates; and achiral compounds, a-hydroxy acids, and APIs and intermediates. Chiral Quest has one manufacturing site in Jiangxi province, and three overseas offices in USA, Europe & India respectively. The company was founded by Xumu Zhang in 2000 and is headquartered in Suzhou, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Colmen Group, Inc.
 The Colmen Group, Inc. Investment Banks/BrokersFinance The Colmen Group, Inc. provides business services. It offers investment banking and consulting services with a focus on both mergers and acquisitions and corporate finance. The company was founded by Peter C. Colella, Jr. in 1981 and is headquartered in Radnor, PA. | Investment Banks/Brokers | Corporate Officer/Principal | |
Citibank Taiwan Ltd.
 Citibank Taiwan Ltd. Major BanksFinance Citibank Taiwan Ltd. provides commercial banking services. It is engaged in receiving various deposits and handles loans, domestic foreign exchange and guarantee business. The company was founded in 1964 and is headquartered in Taipei, Taiwan. | Major Banks | Corporate Officer/Principal | |
| SCISPARC LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
| ARNO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Compliance Certification Services Inc.
 Compliance Certification Services Inc. Miscellaneous Commercial ServicesCommercial Services Compliance Certification Services Inc. provides electromagnetic compliance and wireless testing services. The company was founded in 1989 and is headquartered in Taipei, Taiwan. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Presco Netmarketing, Inc. | Director/Board Member | ||
| President Tokyo Corp. | Director/Board Member | ||
| Sun Yat-Sen University | College/University | Doctorate Degree Graduate Degree | |
| Nortel Networks Asia Pacific | Corporate Officer/Principal | ||
| GENETRON HOLDINGS LIMITED | Medical/Nursing Services | Founder Chief Executive Officer Chief Tech/Sci/R&D Officer | |
President International Development Corp.
 President International Development Corp. Financial ConglomeratesFinance President International Development Corporation is an investment holding company of the Uni-President Group (UPG). The company engages in the management of investments of UPG. It also provides financial consulting services to the subsidiaries of UPG. Its investment scope stretches across the industries of biomedicine, real estate, optoelectronics, consumer goods, financial services, energy, textile, petrochemical, as well as telecommunications. Moreover, it has financial investments in domestic and foreign capital markets. The company was founded on October 8, 1997 and is headquartered in Taipei, Taiwan. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| President Life Sciences Cayman Co. Ltd. | Director/Board Member Director/Board Member | ||
| Tung Ting Gas Corp. | Director/Board Member Director/Board Member | ||
| Puppetmotion Entertainment Co., Ltd. | Director/Board Member Director/Board Member | ||
| SYNERGY SCIENTECH CORP. | Electrical Products | Director/Board Member Director/Board Member | |
Oncolyze, Inc.
 Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 24 |
| Taiwan | 14 |
| China | 5 |
| Kaaimaneilanden | 4 |
| Israël | 4 |
Sectoraal
| Health Technology | 17 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 5 |
| Retail Trade | 3 |
Operationeel
| Director/Board Member | 216 |
| Corporate Officer/Principal | 105 |
| Chairman | 45 |
| Founder | 45 |
| Chief Executive Officer | 43 |
Sterkste connecties
| Insiders | |
|---|---|
| James Topper | 49 |
| Tsung Ming Su | 46 |
| Zuie Chin Huang | 40 |
| Mohammad Azab | 21 |
| David Mack | 19 |
| Stephen Keith | 19 |
| Robert Duggan | 18 |
| J. Craig Venter | 17 |
| Yue Wu | 16 |
| Chiu Ju Shih | 15 |
| Rom Eliaz | 14 |
| Alexander Zukiwski | 12 |
| Gordon S. Macklin | 11 |
| Brett Blundy | 11 |
| Philip Haworth | 10 |
